nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP9—chronic obstructive pulmonary disease	0.302	0.511	CbGaD
Captopril—ACE—chronic obstructive pulmonary disease	0.205	0.347	CbGaD
Captopril—ALB—chronic obstructive pulmonary disease	0.084	0.142	CbGaD
Captopril—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0268	0.215	CbGbCtD
Captopril—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0268	0.215	CbGbCtD
Captopril—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0239	0.191	CbGbCtD
Captopril—ALB—Prednisone—chronic obstructive pulmonary disease	0.0229	0.183	CbGbCtD
Captopril—REN—pulmonary artery—chronic obstructive pulmonary disease	0.0129	0.191	CbGeAlD
Captopril—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0127	0.101	CbGbCtD
Captopril—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.012	0.0956	CbGbCtD
Captopril—F2—leg—chronic obstructive pulmonary disease	0.0061	0.0904	CbGeAlD
Captopril—ACE—pulmonary artery—chronic obstructive pulmonary disease	0.0055	0.0816	CbGeAlD
Captopril—LTA4H—respiratory system—chronic obstructive pulmonary disease	0.00281	0.0417	CbGeAlD
Captopril—LTA4H—connective tissue—chronic obstructive pulmonary disease	0.00248	0.0367	CbGeAlD
Captopril—LTA4H—bronchus—chronic obstructive pulmonary disease	0.00232	0.0343	CbGeAlD
Captopril—LTA4H—smooth muscle tissue—chronic obstructive pulmonary disease	0.00227	0.0336	CbGeAlD
Captopril—REN—respiratory system—chronic obstructive pulmonary disease	0.00217	0.0322	CbGeAlD
Captopril—LTA4H—trachea—chronic obstructive pulmonary disease	0.00208	0.0308	CbGeAlD
Captopril—MMP2—respiratory system—chronic obstructive pulmonary disease	0.002	0.0296	CbGeAlD
Captopril—REN—connective tissue—chronic obstructive pulmonary disease	0.00191	0.0283	CbGeAlD
Captopril—MMP2—connective tissue—chronic obstructive pulmonary disease	0.00176	0.0261	CbGeAlD
Captopril—REN—smooth muscle tissue—chronic obstructive pulmonary disease	0.00175	0.0259	CbGeAlD
Captopril—MMP9—respiratory system—chronic obstructive pulmonary disease	0.00174	0.0257	CbGeAlD
Captopril—MMP2—bronchus—chronic obstructive pulmonary disease	0.00164	0.0244	CbGeAlD
Captopril—MMP2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00161	0.0238	CbGeAlD
Captopril—MMP9—connective tissue—chronic obstructive pulmonary disease	0.00153	0.0227	CbGeAlD
Captopril—Enalapril—ACE—chronic obstructive pulmonary disease	0.00152	1	CrCbGaD
Captopril—F2—respiratory system—chronic obstructive pulmonary disease	0.00152	0.0225	CbGeAlD
Captopril—LTA4H—lung—chronic obstructive pulmonary disease	0.00149	0.0222	CbGeAlD
Captopril—MMP2—trachea—chronic obstructive pulmonary disease	0.00148	0.0219	CbGeAlD
Captopril—MMP9—smooth muscle tissue—chronic obstructive pulmonary disease	0.0014	0.0207	CbGeAlD
Captopril—F2—connective tissue—chronic obstructive pulmonary disease	0.00133	0.0198	CbGeAlD
Captopril—REN—lung—chronic obstructive pulmonary disease	0.00115	0.0171	CbGeAlD
Captopril—MMP2—lung—chronic obstructive pulmonary disease	0.00106	0.0157	CbGeAlD
Captopril—ACE—respiratory system—chronic obstructive pulmonary disease	0.000926	0.0137	CbGeAlD
Captopril—MMP9—lung—chronic obstructive pulmonary disease	0.000922	0.0137	CbGeAlD
Captopril—ACE—connective tissue—chronic obstructive pulmonary disease	0.000815	0.0121	CbGeAlD
Captopril—F2—lung—chronic obstructive pulmonary disease	0.000805	0.0119	CbGeAlD
Captopril—ACE—smooth muscle tissue—chronic obstructive pulmonary disease	0.000745	0.0111	CbGeAlD
Captopril—ACE—lung—chronic obstructive pulmonary disease	0.000492	0.00729	CbGeAlD
Captopril—MMP2—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000434	0.253	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000434	0.253	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000424	0.247	CbGdCrCtD
Captopril—MMP2—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000424	0.247	CbGdCrCtD
Captopril—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000326	0.00483	CbGeAlD
Captopril—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000292	0.00292	CcSEcCtD
Captopril—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00029	0.0029	CcSEcCtD
Captopril—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.00286	CcSEcCtD
Captopril—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000286	0.00286	CcSEcCtD
Captopril—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000283	0.00283	CcSEcCtD
Captopril—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000283	0.00283	CcSEcCtD
Captopril—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000281	0.00281	CcSEcCtD
Captopril—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000281	0.0028	CcSEcCtD
Captopril—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000279	0.00279	CcSEcCtD
Captopril—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00279	CcSEcCtD
Captopril—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000278	0.00277	CcSEcCtD
Captopril—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.00275	CcSEcCtD
Captopril—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000273	0.00273	CcSEcCtD
Captopril—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00272	CcSEcCtD
Captopril—Tension—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00272	CcSEcCtD
Captopril—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00271	CcSEcCtD
Captopril—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00271	CcSEcCtD
Captopril—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00269	CcSEcCtD
Captopril—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00269	CcSEcCtD
Captopril—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00268	CcSEcCtD
Captopril—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000265	0.00264	CcSEcCtD
Captopril—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000264	0.00263	CcSEcCtD
Captopril—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000261	0.00261	CcSEcCtD
Captopril—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.0026	CcSEcCtD
Captopril—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000258	0.00258	CcSEcCtD
Captopril—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.00257	CcSEcCtD
Captopril—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00257	CcSEcCtD
Captopril—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00257	CcSEcCtD
Captopril—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00256	CcSEcCtD
Captopril—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00256	CcSEcCtD
Captopril—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00255	CcSEcCtD
Captopril—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000255	0.00255	CcSEcCtD
Captopril—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00254	CcSEcCtD
Captopril—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00253	CcSEcCtD
Captopril—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00253	CcSEcCtD
Captopril—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00253	CcSEcCtD
Captopril—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000251	0.00251	CcSEcCtD
Captopril—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.0025	CcSEcCtD
Captopril—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00025	0.0025	CcSEcCtD
Captopril—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00248	CcSEcCtD
Captopril—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00246	CcSEcCtD
Captopril—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000245	0.00245	CcSEcCtD
Captopril—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.00245	CcSEcCtD
Captopril—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000243	0.00243	CcSEcCtD
Captopril—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00242	CcSEcCtD
Captopril—Cough—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00242	CcSEcCtD
Captopril—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00242	CcSEcCtD
Captopril—ABCB1—trachea—chronic obstructive pulmonary disease	0.000241	0.00357	CbGeAlD
Captopril—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00024	0.0024	CcSEcCtD
Captopril—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00024	0.00239	CcSEcCtD
Captopril—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00239	CcSEcCtD
Captopril—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.00237	CcSEcCtD
Captopril—Cough—Montelukast—chronic obstructive pulmonary disease	0.000237	0.00237	CcSEcCtD
Captopril—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00236	CcSEcCtD
Captopril—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00236	CcSEcCtD
Captopril—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00236	CcSEcCtD
Captopril—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00236	CcSEcCtD
Captopril—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00236	CcSEcCtD
Captopril—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00236	CcSEcCtD
Captopril—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00236	CcSEcCtD
Captopril—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.00235	CcSEcCtD
Captopril—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.00235	CcSEcCtD
Captopril—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00234	CcSEcCtD
Captopril—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00233	CcSEcCtD
Captopril—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00233	CcSEcCtD
Captopril—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00231	CcSEcCtD
Captopril—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00231	CcSEcCtD
Captopril—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00231	CcSEcCtD
Captopril—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000231	0.0023	CcSEcCtD
Captopril—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.0023	CcSEcCtD
Captopril—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.0023	CcSEcCtD
Captopril—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.00229	CcSEcCtD
Captopril—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00228	CcSEcCtD
Captopril—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00226	CcSEcCtD
Captopril—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00226	CcSEcCtD
Captopril—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00222	CcSEcCtD
Captopril—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00222	CcSEcCtD
Captopril—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00222	CcSEcCtD
Captopril—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000221	0.00221	CcSEcCtD
Captopril—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00221	CcSEcCtD
Captopril—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000221	0.0022	CcSEcCtD
Captopril—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.0022	CcSEcCtD
Captopril—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.0022	CcSEcCtD
Captopril—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.0022	CcSEcCtD
Captopril—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00218	CcSEcCtD
Captopril—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00217	CcSEcCtD
Captopril—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00213	CcSEcCtD
Captopril—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00211	CcSEcCtD
Captopril—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00211	CcSEcCtD
Captopril—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00211	CcSEcCtD
Captopril—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00021	0.0021	CcSEcCtD
Captopril—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.0021	CcSEcCtD
Captopril—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00208	CcSEcCtD
Captopril—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00208	CcSEcCtD
Captopril—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00206	CcSEcCtD
Captopril—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00206	CcSEcCtD
Captopril—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00204	CcSEcCtD
Captopril—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00204	CcSEcCtD
Captopril—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00203	CcSEcCtD
Captopril—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000203	0.00203	CcSEcCtD
Captopril—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00202	CcSEcCtD
Captopril—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.00201	CcSEcCtD
Captopril—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000202	0.00201	CcSEcCtD
Captopril—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00201	CcSEcCtD
Captopril—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00201	CcSEcCtD
Captopril—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.0002	0.002	CcSEcCtD
Captopril—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00199	CcSEcCtD
Captopril—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000199	0.00199	CcSEcCtD
Captopril—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.00199	CcSEcCtD
Captopril—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00199	CcSEcCtD
Captopril—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000198	0.00198	CcSEcCtD
Captopril—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00197	CcSEcCtD
Captopril—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.00196	CcSEcCtD
Captopril—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00195	CcSEcCtD
Captopril—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00195	CcSEcCtD
Captopril—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00195	CcSEcCtD
Captopril—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00194	CcSEcCtD
Captopril—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00193	CcSEcCtD
Captopril—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00193	CcSEcCtD
Captopril—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00193	CcSEcCtD
Captopril—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00192	CcSEcCtD
Captopril—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00191	CcSEcCtD
Captopril—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.0019	CcSEcCtD
Captopril—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.0019	CcSEcCtD
Captopril—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000189	0.00189	CcSEcCtD
Captopril—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00188	CcSEcCtD
Captopril—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.00187	CcSEcCtD
Captopril—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.00187	CcSEcCtD
Captopril—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00186	CcSEcCtD
Captopril—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00186	CcSEcCtD
Captopril—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.00186	CcSEcCtD
Captopril—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00185	CcSEcCtD
Captopril—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.00185	CcSEcCtD
Captopril—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00185	CcSEcCtD
Captopril—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00185	CcSEcCtD
Captopril—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00184	CcSEcCtD
Captopril—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00182	CcSEcCtD
Captopril—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000181	0.00181	CcSEcCtD
Captopril—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00179	CcSEcCtD
Captopril—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00179	CcSEcCtD
Captopril—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00179	CcSEcCtD
Captopril—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00179	CcSEcCtD
Captopril—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000178	0.00178	CcSEcCtD
Captopril—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.00176	CcSEcCtD
Captopril—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.00176	CcSEcCtD
Captopril—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000176	0.00176	CcSEcCtD
Captopril—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00176	CcSEcCtD
Captopril—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000175	0.00175	CcSEcCtD
Captopril—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00175	CcSEcCtD
Captopril—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00175	CcSEcCtD
Captopril—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00174	CcSEcCtD
Captopril—ABCB1—lung—chronic obstructive pulmonary disease	0.000173	0.00257	CbGeAlD
Captopril—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00172	CcSEcCtD
Captopril—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00169	CcSEcCtD
Captopril—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00169	CcSEcCtD
Captopril—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000166	0.00166	CcSEcCtD
Captopril—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00162	CcSEcCtD
Captopril—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00162	CcSEcCtD
Captopril—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.0016	CcSEcCtD
Captopril—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00016	0.0016	CcSEcCtD
Captopril—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00016	0.0016	CcSEcCtD
Captopril—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00159	CcSEcCtD
Captopril—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00157	CcSEcCtD
Captopril—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00155	CcSEcCtD
Captopril—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00155	CcSEcCtD
Captopril—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00153	CcSEcCtD
Captopril—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00153	CcSEcCtD
Captopril—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00151	CcSEcCtD
Captopril—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00151	CcSEcCtD
Captopril—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00149	CcSEcCtD
Captopril—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00149	CcSEcCtD
Captopril—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00146	CcSEcCtD
Captopril—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00146	CcSEcCtD
Captopril—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00146	CcSEcCtD
Captopril—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00144	CcSEcCtD
Captopril—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00144	CcSEcCtD
Captopril—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00144	CcSEcCtD
Captopril—Rash—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00142	CcSEcCtD
Captopril—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00142	CcSEcCtD
Captopril—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00142	CcSEcCtD
Captopril—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00142	CcSEcCtD
Captopril—Headache—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00141	CcSEcCtD
Captopril—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00141	CcSEcCtD
Captopril—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00141	CcSEcCtD
Captopril—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00141	CcSEcCtD
Captopril—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00141	CcSEcCtD
Captopril—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000141	0.00141	CcSEcCtD
Captopril—Rash—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00139	CcSEcCtD
Captopril—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00139	CcSEcCtD
Captopril—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00139	CcSEcCtD
Captopril—Headache—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00139	CcSEcCtD
Captopril—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00137	CcSEcCtD
Captopril—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00136	CcSEcCtD
Captopril—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00135	CcSEcCtD
Captopril—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00134	CcSEcCtD
Captopril—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00134	CcSEcCtD
Captopril—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00134	CcSEcCtD
Captopril—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00134	CcSEcCtD
Captopril—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00134	CcSEcCtD
Captopril—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00134	CcSEcCtD
Captopril—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00132	CcSEcCtD
Captopril—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00131	CcSEcCtD
Captopril—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00127	CcSEcCtD
Captopril—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00126	CcSEcCtD
Captopril—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00124	CcSEcCtD
Captopril—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00122	CcSEcCtD
Captopril—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.0012	CcSEcCtD
Captopril—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00119	CcSEcCtD
Captopril—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00116	CcSEcCtD
Captopril—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00111	CcSEcCtD
Captopril—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00111	CcSEcCtD
Captopril—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.0011	CcSEcCtD
Captopril—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00103	CcSEcCtD
Captopril—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00101	CcSEcCtD
Captopril—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.00101	CcSEcCtD
Captopril—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00101	CcSEcCtD
Captopril—Angioedema—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.000995	CcSEcCtD
Captopril—Malaise—Prednisone—chronic obstructive pulmonary disease	9.83e-05	0.000982	CcSEcCtD
Captopril—Syncope—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000977	CcSEcCtD
Captopril—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	9.58e-05	0.000957	CcSEcCtD
Captopril—Arthralgia—Prednisone—chronic obstructive pulmonary disease	9.28e-05	0.000927	CcSEcCtD
Captopril—Myalgia—Prednisone—chronic obstructive pulmonary disease	9.28e-05	0.000927	CcSEcCtD
Captopril—Discomfort—Prednisone—chronic obstructive pulmonary disease	9.17e-05	0.000916	CcSEcCtD
Captopril—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	8.9e-05	0.000889	CcSEcCtD
Captopril—Shock—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000875	CcSEcCtD
Captopril—Tachycardia—Prednisone—chronic obstructive pulmonary disease	8.68e-05	0.000868	CcSEcCtD
Captopril—Anorexia—Prednisone—chronic obstructive pulmonary disease	8.48e-05	0.000847	CcSEcCtD
Captopril—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.1e-05	0.00081	CcSEcCtD
Captopril—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.1e-05	0.000809	CcSEcCtD
Captopril—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.05e-05	0.000804	CcSEcCtD
Captopril—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	7.99e-05	0.000798	CcSEcCtD
Captopril—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	7.83e-05	0.000782	CcSEcCtD
Captopril—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.000773	CcSEcCtD
Captopril—Rash—Prednisolone—chronic obstructive pulmonary disease	7.72e-05	0.000771	CcSEcCtD
Captopril—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7.71e-05	0.000771	CcSEcCtD
Captopril—Fatigue—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.000766	CcSEcCtD
Captopril—Headache—Prednisolone—chronic obstructive pulmonary disease	7.67e-05	0.000766	CcSEcCtD
Captopril—Constipation—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.00076	CcSEcCtD
Captopril—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	7.33e-05	0.000732	CcSEcCtD
Captopril—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	7.27e-05	0.000727	CcSEcCtD
Captopril—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.27e-05	0.000727	CcSEcCtD
Captopril—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000703	CcSEcCtD
Captopril—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000703	CcSEcCtD
Captopril—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.41e-05	0.000566	CbGpPWpGaD
Captopril—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.000638	CcSEcCtD
Captopril—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	6.36e-05	0.000562	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	6.31e-05	0.000558	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	6.31e-05	0.000558	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	6.3e-05	0.000557	CbGpPWpGaD
Captopril—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000629	CcSEcCtD
Captopril—MMP2—Developmental Biology—LEP—chronic obstructive pulmonary disease	6.29e-05	0.000556	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	6.28e-05	0.000555	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	6.25e-05	0.000553	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	6.24e-05	0.000552	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	6.1e-05	0.000539	CbGpPWpGaD
Captopril—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.09e-05	0.000608	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	6e-05	0.00053	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IL6—chronic obstructive pulmonary disease	5.95e-05	0.000526	CbGpPWpGaD
Captopril—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000588	CcSEcCtD
Captopril—F2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	5.86e-05	0.000518	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	5.83e-05	0.000516	CbGpPWpGaD
Captopril—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.66e-05	0.000565	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	5.64e-05	0.000499	CbGpPWpGaD
Captopril—Rash—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.00056	CcSEcCtD
Captopril—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.00056	CcSEcCtD
Captopril—F2—Hemostasis—TGFB2—chronic obstructive pulmonary disease	5.59e-05	0.000494	CbGpPWpGaD
Captopril—Headache—Prednisone—chronic obstructive pulmonary disease	5.57e-05	0.000557	CcSEcCtD
Captopril—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	5.57e-05	0.000493	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	5.54e-05	0.00049	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	5.46e-05	0.000483	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.37e-05	0.000475	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	5.34e-05	0.000472	CbGpPWpGaD
Captopril—MMP2—Axon guidance—MMP9—chronic obstructive pulmonary disease	5.3e-05	0.000468	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	5.29e-05	0.000468	CbGpPWpGaD
Captopril—Nausea—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000528	CcSEcCtD
Captopril—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.26e-05	0.000465	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	5.16e-05	0.000456	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	5.14e-05	0.000455	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	5.13e-05	0.000454	CbGpPWpGaD
Captopril—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	5.09e-05	0.00045	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	5.02e-05	0.000443	CbGpPWpGaD
Captopril—F2—Hemostasis—HDAC2—chronic obstructive pulmonary disease	5.01e-05	0.000443	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	4.96e-05	0.000439	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	4.96e-05	0.000438	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	4.96e-05	0.000438	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.94e-05	0.000436	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.93e-05	0.000435	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.88e-05	0.000431	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	4.85e-05	0.000429	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	4.84e-05	0.000428	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.81e-05	0.000425	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ALB—chronic obstructive pulmonary disease	4.76e-05	0.000421	CbGpPWpGaD
Captopril—MMP2—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.76e-05	0.00042	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	4.76e-05	0.00042	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	4.75e-05	0.00042	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.73e-05	0.000418	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.63e-05	0.000409	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.58e-05	0.000405	CbGpPWpGaD
Captopril—LTA4H—Metabolism—NOS3—chronic obstructive pulmonary disease	4.55e-05	0.000402	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	4.55e-05	0.000402	CbGpPWpGaD
Captopril—F2—Hemostasis—PLAUR—chronic obstructive pulmonary disease	4.52e-05	0.000399	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	4.51e-05	0.000399	CbGpPWpGaD
Captopril—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	4.45e-05	0.000393	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	4.36e-05	0.000386	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	4.35e-05	0.000384	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.33e-05	0.000383	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	4.3e-05	0.00038	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.3e-05	0.00038	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.29e-05	0.000379	CbGpPWpGaD
Captopril—MMP2—Axon guidance—EGFR—chronic obstructive pulmonary disease	4.28e-05	0.000378	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	4.25e-05	0.000376	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	4.2e-05	0.000371	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.13e-05	0.000365	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	4.05e-05	0.000358	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	4.04e-05	0.000357	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	4.03e-05	0.000356	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	3.96e-05	0.00035	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	3.94e-05	0.000348	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.94e-05	0.000348	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.93e-05	0.000348	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.85e-05	0.00034	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.8e-05	0.000336	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.8e-05	0.000335	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.78e-05	0.000334	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.76e-05	0.000332	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.73e-05	0.00033	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.63e-05	0.000321	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	3.6e-05	0.000318	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	3.55e-05	0.000314	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.39e-05	0.0003	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	3.37e-05	0.000298	CbGpPWpGaD
Captopril—MMP2—Axon guidance—IL6—chronic obstructive pulmonary disease	3.29e-05	0.000291	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.27e-05	0.000289	CbGpPWpGaD
Captopril—F2—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.23e-05	0.000285	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	3.22e-05	0.000285	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.21e-05	0.000284	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	3.2e-05	0.000283	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	3.19e-05	0.000282	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.18e-05	0.000281	CbGpPWpGaD
Captopril—F2—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.17e-05	0.00028	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.17e-05	0.00028	CbGpPWpGaD
Captopril—MMP9—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.12e-05	0.000276	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.12e-05	0.000275	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	3.06e-05	0.00027	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.05e-05	0.00027	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.05e-05	0.00027	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.01e-05	0.000266	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.01e-05	0.000266	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	3e-05	0.000265	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	2.99e-05	0.000264	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.95e-05	0.000261	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	2.93e-05	0.000259	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	2.93e-05	0.000259	CbGpPWpGaD
Captopril—F2—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.91e-05	0.000257	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.91e-05	0.000257	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.91e-05	0.000257	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	2.9e-05	0.000256	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.9e-05	0.000256	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.88e-05	0.000255	CbGpPWpGaD
Captopril—MMP9—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.81e-05	0.000248	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.8e-05	0.000247	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	2.79e-05	0.000246	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.76e-05	0.000244	CbGpPWpGaD
Captopril—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	2.72e-05	0.000241	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.72e-05	0.00024	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.69e-05	0.000238	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	2.69e-05	0.000237	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	2.59e-05	0.000229	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	2.58e-05	0.000228	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	2.56e-05	0.000226	CbGpPWpGaD
Captopril—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	2.56e-05	0.000226	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	2.54e-05	0.000225	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.47e-05	0.000218	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	2.46e-05	0.000217	CbGpPWpGaD
Captopril—F2—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.45e-05	0.000217	CbGpPWpGaD
Captopril—F2—Hemostasis—ALB—chronic obstructive pulmonary disease	2.45e-05	0.000216	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.43e-05	0.000215	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	2.39e-05	0.000211	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.38e-05	0.00021	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.36e-05	0.000209	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.35e-05	0.000208	CbGpPWpGaD
Captopril—F2—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.34e-05	0.000207	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.32e-05	0.000205	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.32e-05	0.000205	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.32e-05	0.000205	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.31e-05	0.000204	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.25e-05	0.000199	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.23e-05	0.000197	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.22e-05	0.000196	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.22e-05	0.000196	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.2e-05	0.000195	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.2e-05	0.000194	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.18e-05	0.000193	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—chronic obstructive pulmonary disease	2.16e-05	0.000191	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.12e-05	0.000188	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.05e-05	0.000181	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.04e-05	0.000181	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2e-05	0.000177	CbGpPWpGaD
Captopril—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	1.99e-05	0.000176	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.94e-05	0.000172	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.93e-05	0.00017	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.91e-05	0.000169	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.89e-05	0.000167	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	1.89e-05	0.000167	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	1.88e-05	0.000166	CbGpPWpGaD
Captopril—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.8e-05	0.00016	CbGpPWpGaD
Captopril—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.79e-05	0.000158	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.79e-05	0.000158	CbGpPWpGaD
Captopril—ALB—Metabolism—GC—chronic obstructive pulmonary disease	1.76e-05	0.000155	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.7e-05	0.00015	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.69e-05	0.000149	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.69e-05	0.000149	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	1.63e-05	0.000144	CbGpPWpGaD
Captopril—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.63e-05	0.000144	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.62e-05	0.000143	CbGpPWpGaD
Captopril—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.58e-05	0.00014	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.58e-05	0.00014	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.55e-05	0.000137	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.54e-05	0.000136	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.54e-05	0.000136	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.53e-05	0.000136	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.49e-05	0.000132	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.48e-05	0.00013	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.46e-05	0.000129	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.45e-05	0.000128	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.43e-05	0.000126	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.4e-05	0.000124	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.37e-05	0.000121	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.35e-05	0.000119	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.31e-05	0.000116	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.3e-05	0.000115	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.3e-05	0.000115	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.3e-05	0.000115	CbGpPWpGaD
Captopril—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.28e-05	0.000113	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.28e-05	0.000113	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—chronic obstructive pulmonary disease	1.27e-05	0.000113	CbGpPWpGaD
Captopril—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.26e-05	0.000111	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.23e-05	0.000108	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.19e-05	0.000105	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.19e-05	0.000105	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.18e-05	0.000105	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.17e-05	0.000104	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.16e-05	0.000102	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.15e-05	0.000102	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.14e-05	0.000101	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.1e-05	9.68e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.08e-05	9.52e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.06e-05	9.36e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.03e-05	9.08e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	9.73e-06	8.6e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.66e-06	8.54e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.59e-06	8.48e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	9.48e-06	8.38e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	9.29e-06	8.21e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.12e-06	8.06e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.71e-06	7.7e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	8.65e-06	7.65e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.4e-06	7.43e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.31e-06	7.35e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.31e-06	7.34e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.97e-06	7.05e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.94e-06	7.01e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.92e-06	7e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.83e-06	6.92e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.58e-06	6.7e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.4e-06	6.55e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.36e-06	6.51e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.14e-06	6.31e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.04e-06	6.22e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.98e-06	6.17e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.8e-06	6.01e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.69e-06	5.92e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.69e-06	5.91e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.66e-06	5.89e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.65e-06	5.88e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.58e-06	5.82e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.56e-06	5.8e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.37e-06	5.63e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	6.14e-06	5.43e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.11e-06	5.4e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.82e-06	5.15e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.79e-06	5.12e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.74e-06	5.08e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.72e-06	5.05e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.59e-06	4.95e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.49e-06	4.85e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.41e-06	4.78e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.35e-06	4.73e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.25e-06	4.64e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.14e-06	4.55e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.12e-06	4.53e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.07e-06	4.49e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	5.06e-06	4.47e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.04e-06	4.46e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.78e-06	4.23e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.32e-06	3.82e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.95e-06	3.5e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	3.77e-06	3.33e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.45e-06	3.05e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.3e-06	2.92e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.25e-06	2.87e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.11e-06	2.75e-05	CbGpPWpGaD
